SU923547A1 - Method of treating bronchial asthma - Google Patents
Method of treating bronchial asthma Download PDFInfo
- Publication number
- SU923547A1 SU923547A1 SU802994039A SU2994039A SU923547A1 SU 923547 A1 SU923547 A1 SU 923547A1 SU 802994039 A SU802994039 A SU 802994039A SU 2994039 A SU2994039 A SU 2994039A SU 923547 A1 SU923547 A1 SU 923547A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- bronchial asthma
- treating bronchial
- patient
- irradiated
- days
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
(54) СПОСОБ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ(54) METHOD FOR TREATING BRONCHIAL ASTHMA
1one
Изобретение относитс к медицине, а именно к аллергологии.The invention relates to medicine, namely to allergology.
Известен способ лечени бронхиальной астмы путем введени гормональных и иммунодепрессивных питое татических препаратов 1 .There is a method of treating bronchial asthma by administering hormonal and immunosuppressive nutritional drugs 1.
Однако известный способ вызывает развитие различных осложнений и р д побочных влений, которые могут прев-, зойти по т жести бронхиальную астму, что ограничивает диапазон применени известного способа и осложн ет лечение.However, the known method causes the development of various complications and a number of side effects that can translate into severity of bronchial asthma, which limits the range of application of the known method and complicates treatment.
Цель изобретени - устранение побочных влений.The purpose of the invention is the elimination of side effects.
Указанна цель достигаетс тем, что согласно способу лечени бронхиальной астмы путем введени гормональных и иммунодепрессивных ци тоста тических препаратов , больному внутривенно ввод т изолированно облученную вне организма аутокроБЬ по 6 - 7 вливаний на курс с интервалами 2-3 дн .This goal is achieved by the fact that, according to the method of treating bronchial asthma by administering hormonal and immunosuppressive cytostatic drugs, the patient is intravenously injected with an autocropoietic 6–7 infusions irradiated outside the body for 2–3 days.
Способ осуществл ют следующим образом .The method is carried out as follows.
У больного путем венопункини забирают 2ОО -25О г крови в стерильный флакон с консервантом, облучают ее рентгеновскими лучами, выдерживают 20 ч при температуре -2°С и затем внутривенно капельноструйно ввод т тому же больному всю облученную аутокровь. После 2-3 дневного перерыва данную процедуру повтор ют 6-7 раз, с инте1 валами между введени ми 2-3 дн , в том же объеме забираемой крови, облучении ее, охлаждении при температуре -2°С в течение 20ч и последующем введением больному как и в первый день.A patient with venopunkin is taken 2OO -25O g of blood into a sterile vial with preservative, irradiated with x-rays, kept for 20 hours at a temperature of -2 ° C, and then the entire irradiated autologous blood was introduced by intravenous drip-drop. After a 2-3 day break, this procedure is repeated 6-7 times, with intervals between injections for 2-3 days, in the same volume of blood taken, irradiated, cooled at a temperature of -2 ° C for 20 hours, and then administered to a patient like the first day.
П р и м е р. 1. Больной К., 39 лет, диагноз : инфекционно-аллергическа и атопическа бронхиальна астма, I стади . Осложнени : эмфизема легких, пнев- москлероз, дыхательна недостаточность L степени по смешанному типу, стероидозависимость . Назначено многократное введение изолированно облученной аутокрови . Кровь больного в количестве 250 гр забиралась в стерильную ампулу с конPRI me R. 1. Patient K., 39 years old, diagnosed with infectious-allergic and atopic bronchial asthma, stage I. Complications: emphysema of the lungs, pneumosclerosis, respiratory insufficiency of the L degree of mixed type, steroid dependence. Repeated administration of isolated, irradiated autologous blood was indicated. The patient's blood in the amount of 250 grams was taken into a sterile ampoule with con
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU802994039A SU923547A1 (en) | 1980-10-13 | 1980-10-13 | Method of treating bronchial asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU802994039A SU923547A1 (en) | 1980-10-13 | 1980-10-13 | Method of treating bronchial asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU923547A1 true SU923547A1 (en) | 1982-04-30 |
Family
ID=20922274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU802994039A SU923547A1 (en) | 1980-10-13 | 1980-10-13 | Method of treating bronchial asthma |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU923547A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0190417A2 (en) * | 1985-01-10 | 1986-08-13 | Paal's Packpressen-Fabrik GmbH & Co. KG | Device for comminuting waste paper |
-
1980
- 1980-10-13 SU SU802994039A patent/SU923547A1/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0190417A2 (en) * | 1985-01-10 | 1986-08-13 | Paal's Packpressen-Fabrik GmbH & Co. KG | Device for comminuting waste paper |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Creditor et al. | Effect of ACTH on wound healing in humans. | |
| KR880000191B1 (en) | A inhibiting the onset of acute radiation syndrome and a composition | |
| SU923547A1 (en) | Method of treating bronchial asthma | |
| Mihindukulasuriya et al. | A case of paraparesis due to extramedullary haemopoiesis in HbE-thalassaemia | |
| Thompson et al. | Stimulation of local antibody formation in cornea by Grenz Rays | |
| US4302452A (en) | Use of derivatives of 6α-methylprednisolone as an antiemetic | |
| SU1261665A1 (en) | Method of treatment of thymomegalia of children | |
| EP0213072B1 (en) | Treatment of chronic imflammatory disease | |
| Childs | Further Clinical Trials of Amphotericin; with a Report on the Treatment of a Probable Case of Generalised Moniliasis | |
| RU2005512C1 (en) | Method for treatment of destructive pancreatitis | |
| SU1134197A1 (en) | Method of treatment of tuberculosis | |
| SU950388A1 (en) | Pulmonary tuberculosis patients treatment method | |
| RU2203667C2 (en) | Method for treating lymphoproliferative diseases | |
| Schumacher et al. | Immunosuppressive properties and side effects of E. coli L-asparaginase | |
| SU858850A1 (en) | Method of treating posttuberculosis cicatrix changing of tissue | |
| SU1690782A1 (en) | Method for anesthesia application during surgery | |
| HUNT | Current challenges for wound healing research | |
| SU1268171A1 (en) | Method of prophylaxis of acute adrenocortical insufficiency in surgical operations | |
| US4296124A (en) | Pharmaceutical methods | |
| SU1232257A1 (en) | Method of treatment of pulmonary tuberculosis | |
| RU2092107C1 (en) | Method for treatment hepatic insufficiency in patients affected with ascites | |
| SU1367975A1 (en) | Method of treatment of destructive tuberculosis of the lungs | |
| SU1537261A1 (en) | Method of treating hematogenic osteomyelitis of infants | |
| RU2243776C1 (en) | Method for treatment of pulmonary tuberculosis | |
| RU2063162C1 (en) | Method for treating the cases of chronic prostatitis |